Michael Steinmetz insider trades: Tetralogic Pharmaceuticals (TLOG) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Michael reports to the SEC
and 29 more companies
Open-market buys and sales
82 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 9, 2016 | TLOG | ↓ Sell | 333,630 | $0.17 | $56K | Direct | Feb 10, 2016 (1d) |
| Feb 5, 2016 | TLOG | ↓ Sell | 1,415,490 | $0.18 | $249K | Direct | Feb 5, 2016 (0d) |
| Feb 2, 2016 | TLOG | ↓ Sell | 369,132 | $0.19 | $72K | Direct | Feb 2, 2016 (0d) |
| Jan 28, 2016 | TLOG | ↓ Sell | 311,930 | $0.28 | $86K | Direct | Jan 28, 2016 (0d) |
| Jan 8, 2015 | AERI | ↓ Sell | 175,000 | $31.11 | $5.4M | Direct | Jan 12, 2015 (4d) |
| Jan 5, 2015 | AERI | ↓ Sell | 23,620 | $30.86 | $729K | Direct | Jan 6, 2015 (1d) |
| Dec 29, 2014 | AERI | ↓ Sell | 80,724 | $30.05 | $2.4M | Direct | Dec 30, 2014 (1d) |
| Dec 23, 2014 | AERI | ↓ Sell | 49,704 | $30.36 | $1.5M | Direct | Dec 24, 2014 (1d) |
| Jun 11, 2014 | OPHT | ↓ Sell | 211,180 | $45.42 | $9.6M | Direct | Jun 11, 2014 (0d) |
| Jun 11, 2014 | OPHT | ↓ Sell | 500 | $44.32 | $22K | Indirect | Jun 11, 2014 (0d) |
| Dec 17, 2013 | TLOG | ↑ Buy | 1,425,063 | $7.00 | $10.0M | Direct | Dec 19, 2013 (2d) |
| Oct 25, 2013 | AERI | ↑ Buy | 321,000 | $10.00 | $3.2M | Direct | Oct 28, 2013 (3d) |
| Aug 8, 2012 | GMED | ↓ Sell | 804,232 | $11.16 | $9.0M | By Fund | Aug 10, 2012 (2d) |
| Jul 9, 2012 | SOMX | ↓ Sell | 2,295,791 | $0.30 | $694K | Indirect | Jul 10, 2012 (1d) |
| Jul 3, 2012 | SOMX | ↓ Sell | 178,558 | $0.29 | $52K | Indirect | Jul 5, 2012 (2d) |
| Jun 28, 2012 | SOMX | ↓ Sell | 19,500 | $0.29 | $6K | Indirect | Jul 2, 2012 (4d) |
| Jun 19, 2012 | SOMX | ↓ Sell | 12,000 | $0.29 | $3K | Indirect | Jun 21, 2012 (2d) |
| Jun 15, 2012 | SOMX | ↓ Sell | 1,450 | $0.29 | $420 | Indirect | Jun 19, 2012 (4d) |
| Jun 6, 2012 | SOMX | ↓ Sell | 37,955 | $0.29 | $11K | Indirect | Jun 7, 2012 (1d) |
| May 31, 2012 | ACHN | ↓ Sell | 1,316,956 | $7.49 | $9.9M | By Fund | Jun 4, 2012 (4d) |
| May 31, 2012 | SOMX | ↓ Sell | 811,422 | $0.30 | $244K | Indirect | Jun 4, 2012 (4d) |
| Oct 27, 2011 | ZLCS | ↓ Sell | 738,807 | $1.03 | $761K | Indirect | Oct 28, 2011 (1d) |
| Oct 26, 2011 | ZLCS | ↓ Sell | 281,200 | $1.02 | $287K | Indirect | Oct 27, 2011 (1d) |
| Oct 24, 2011 | ZLCS | ↓ Sell | 322,100 | $1.03 | $331K | Indirect | Oct 25, 2011 (1d) |
| Oct 20, 2011 | ZLCS | ↓ Sell | 459,817 | $1.03 | $473K | Indirect | Oct 21, 2011 (1d) |
| Oct 17, 2011 | ZLCS | ↓ Sell | 19,644 | $1.02 | $20K | Indirect | Oct 19, 2011 (2d) |
| Oct 14, 2011 | ZLCS | ↓ Sell | 44,700 | $1.02 | $46K | Indirect | Oct 17, 2011 (3d) |
| Oct 12, 2011 | ZLCS | ↓ Sell | 338,300 | $40.36 | $13.7M | Indirect | Oct 13, 2011 (1d) |
| Oct 10, 2011 | ZLCS | ↓ Sell | 505,200 | $1.03 | $523K | Indirect | Oct 11, 2011 (1d) |
| Oct 6, 2011 | ZLCS | ↓ Sell | 380,232 | $1.02 | $388K | Indirect | Oct 6, 2011 (0d) |
| Sep 27, 2011 | ZLCS | ↓ Sell | 410,000 | $1.10 | $451K | Indirect | Sep 28, 2011 (1d) |
| Sep 16, 2011 | ZGNX | ↑ Buy | 3,500,000 | $2.00 | $7.0M | By Fund | Sep 20, 2011 (4d) |
| Nov 29, 2010 | ZGNX | ↑ Buy | 1,750,000 | $4.00 | $7.0M | Direct | Nov 30, 2010 (1d) |
| Nov 9, 2010 | AVNR | ↓ Sell | 1,244,626 | $4.82 | $6.0M | By Fund | Nov 10, 2010 (1d) |
| Nov 5, 2010 | AVNR | ↓ Sell | 1,732,678 | $4.58 | $7.9M | By Fund | Nov 5, 2010 (0d) |
| Nov 3, 2010 | PIP | ↑ Buy | 430,000 | $3.50 | $1.5M | Indirect | Nov 5, 2010 (2d) |
| Nov 2, 2010 | AVNR | ↓ Sell | 5,193,960 | $5.06 | $26.3M | By Fund | Nov 2, 2010 (0d) |
| Oct 11, 2010 | AVNR | ↓ Sell | 551,838 | $3.50 | $1.9M | By Fund | Oct 12, 2010 (1d) |
| Aug 20, 2010 | ACHN | ↑ Buy | 4,875,502 | $2.49 | $12.1M | By Fund | Aug 20, 2010 (0d) |
| Jul 13, 2010 | AVNR | ↓ Sell | 165,000 | $3.53 | $583K | By Fund | Jul 15, 2010 (2d) |
| Jun 28, 2010 | SENO | ↓ Sell | 207,893 | $10.97 | $2.3M | Indirect | Jun 29, 2010 (1d) |
| Apr 27, 2010 | SENO | ↓ Sell | 14,900 | $10.09 | $150K | Indirect | Apr 28, 2010 (1d) |
| Apr 23, 2010 | SENO | ↓ Sell | 33,711 | $10.06 | $339K | Indirect | Apr 26, 2010 (3d) |
| Jan 11, 2010 | ACHN | ↓ Sell | 233,990 | $3.77 | $881K | By Fund | Jan 13, 2010 (2d) |
| Jan 7, 2010 | ACHN | ↓ Sell | 53,000 | $3.50 | $186K | By Fund | Jan 8, 2010 (1d) |
| Dec 24, 2009 | ACHN | ↓ Sell | 3,600 | $3.53 | $13K | By Fund | Dec 29, 2009 (5d) |
| Dec 23, 2009 | ACHN | ↓ Sell | 284,000 | $3.69 | $1.0M | By Fund | Dec 23, 2009 (0d) |
| Dec 18, 2009 | ACHN | ↓ Sell | 207,176 | $3.53 | $730K | By Fund | Dec 18, 2009 (0d) |
| Nov 9, 2009 | PARD | ↓ Sell | 494,962 | $8.19 | $4.1M | Indirect | Nov 9, 2009 (0d) |
| Jul 8, 2009 | SOMX | ↑ Buy | 1,276,593 | $1.05 | $1.3M | Indirect | Jul 9, 2009 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Michael Steinmetz's insider trades
Michael Steinmetz is a 10% owner of Tetralogic Pharmaceuticals (TLOG). Since Jun 20, 2005, Michael has reported 24 open-market purchases worth $86.8M and 58 sales worth $140.4M on SEC Form 4. There have been no open-market trades in the last 12 months.
4 sales (2% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include other transactions (33 filings), conversions (22 filings), option exercises (7 filings), grants and awards (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TLOG insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.